ESMO 2023 | Patient Advocacy Track highlights challenges in access, caregiver support and digitalisationConferences, MPE27 October 2023
MPE to present at European Society for Medical Oncology (ESMO) Annual Congress 2023Conferences, MPE17 October 2023
Sign up for the MPE webinar on EHA myeloma and AL amyloidosis highlights AL amyloidosis, Conferences, MPE, Myeloma14 June 2023
EHA 2023 highlights in myeloma and AL amyloidosisAL amyloidosis, Conferences, Myeloma, Videos14 June 2023
ASH 2022 | Myeloma and AL amyloidosis updatesAL amyloidosis, Conferences, Myeloma, Videos12 December 2022
EHA 2021| Daratumumab plus lenalidomide and dexamethasone (D-Rd) shows overall survival benefit in elderly patients with transplant-ineligible newly diagnosed myelomaConferences, Myeloma14 June 2021
EHA 2021 | Daratumumab maintenance improves Progression-Free Survival (PFS) after autologous stem cell transplantation in myelomaConferences, Myeloma13 June 2021
EHA 2021 | Patient preferences in myeloma, a qualitative multinational study in myelomaConferences, Myeloma11 June 2021
